SFBS, WSFS and HFWA within the Zacks Savings & Loan Industry will gain on lower interest rates. Also, digital upgrades will improve operating efficiency.
Source: https://www.zacks.com/commentary/2874083/savings-loan-indust…
AbbVie is a Dividend King, poised for strong growth with Rinvoq and Skyrizi. Eli Lilly has taken control of the obesity drug market, with major possibilities ahead.
A growing number of companies are looking like compelling AI plays. Microsoft offers a more traditional path to invest in the power of AI.
Eli Lilly is at the forefront of the GLP-1 weight loss drug market. The company’s leading position is already being tested by Novo Nordisk’s GLP-1 weight loss pill.
